Benoît Dupont

Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis

Delphine Mariotte, Benoît Dupont, Radj Gervais et al. · mAbs · 2011 · 60 citations · Full text

Life Sciences, Immunology, Oncology +17

Randomised clinical trial: enteral nutrition does not improve the long‐term outcome of alcoholic cirrhotic patients with jaundice

Benoît Dupont, Thông Dao, Christophe Joubert et al. · Alimentary Pharmacology & Therapeutics · 2012 · 46 citations

Agriculture, Nutrition, Nutritional Sciences +17

Digestive and genitourinary sequelae in rectal cancer survivors and their impact on health-related quality of life: Outcome of a high-resolution population-based study

Yassine Eid, Véronique Bouvier, Benjamin Menahem et al. · Surgery · 2019 · 38 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics

Mamatha Bhat, Peter Ghali, Benoît Dupont et al. · Journal of Hepatology · 2016 · 25 citations

Medicine, Oncology, Neoplasia +15

Utility of serum anti‐cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab

Benoît Dupont, Delphine Mariotte, Audrey Emmanuelle Dugué et al. · British Journal of Clinical Pharmacology · 2016 · 22 citations · Full text

Medicine, Oncology, Pharmacology +17